Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sathishkumar Baskaran
Observed name:
S. Baskaran
Institution:
Olink (United States)
Observed institutions:
Uppsala University,
Stockholm University,
Science for Life Laboratory,
Sahlgrenska University Hospital,
Olink (United States),
Chalmers University of Technology,
University of Gothenburg
show all 7
ORCID:
0000-0002-5089-7333
Observed ORCID:
0000-0002-5089-7333
OpenAlex ID:
A5041958317
The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes
2015
·
Yuan Xie
, Tobias Bergström
, et al.
·
EBioMedicine
·
332
PDF
A combined approach for single-cell mRNA and intracellular protein expression analysis
2021
·
Johan Reimegård
, Marcel Tarbier
, et al.
·
Communications Biology
·
141
PDF
A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma
2020
·
Patrik Johansson
, Cecilia Krona
, et al.
·
Cell Reports
·
71
PDF
Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus
2016
·
Mohanraj Ramachandran
, Di Yu
, et al.
·
Clinical Cancer Research
·
56
Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages
2018
·
Sathishkumar Baskaran
, Markus Mayrhofer
, et al.
·
Neuro-Oncology
·
35
PDF
Case-specific potentiation of glioblastoma drugs by pterostilbene
2016
·
Linnéa Schmidt
, Sathishkumar Baskaran
, et al.
·
Oncotarget
·
23
PDF
Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions
2013
·
L. Schmidt
, T. Kling
, et al.
·
Neuro-Oncology
·
23
PDF
Joslin Kidney Panel of Circulating Proteins: A Tool for ESKD Risk Discrimination and Individualized Diabetic Kidney Disease Treatment
2025
·
Andrzej S. Krolewski
, Jani K. Haukka
, et al.
·
Clinical Journal of the American Society of Nephrology
·
5
Supplementary data from Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus
2023
·
Mohanraj Ramachandran
, Di Yu
, et al.
Supplementary data from Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus
2023
·
Mohanraj Ramachandran
, Di Yu
, et al.
Data from Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus
2023
·
Mohanraj Ramachandran
, Di Yu
, et al.
Data from Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus
2023
·
Mohanraj Ramachandran
, Di Yu
, et al.
Decoding glioblastoma drug responses using an open access library of patient derived cell models
2018
·
Patrik Johansson
, Linnéa Schmidt
, et al.
New Molecular Approaches to Glioblastoma Therapy
2017
·
Sathishkumar Baskaran
·
KTH Publication Database DiVA (KTH Royal Institute of Technology)
Targeting tumor heterogeneity: multi-omic modeling of glioblastoma drug response using an open-access library of patient-derived cells
2017
·
Patrik Johansson
, Linnéa Schmidt
, et al.
Loss of transcription factor ZBTB16 induces cell death in patient-derived GBM cell lines
2017
·
Sathishkumar Baskaran
, Patrik Johansson
, et al.
Show more works
View as search
Works count:
16
Citation count:
686
H-index:
7
I10-index:
7
Year
Topic
Type
